Kolexia
Joussain Charles Médecine physique
Joussain Charles
Médecine physique
Hôpital Raymond-Poincaré
Garches, France
82 Activités
2 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Dysfonctionnement érectile Vessie neurologique Vessie hyperactive Traumatismes de la moelle épinière Sclérose Symptômes de l'appareil urinaire inférieur Sclérose en plaques Incontinence urinaire Défaillance cardiaque

Collaborateurs

Voir plus
Denys Pierre
Denys Pierre
Hôpital Raymond-Poincaré, Garches, France
Gremeaux Vincent
Gremeaux Vincent
CHU Dijon-Bourgogne, Dijon, France
Phe Veronique
Phe Veronique
Hôpital Pitie Salpetriere, Paris, France
Giuliano Francois
Giuliano Francois
Hôpital Raymond-Poincaré, Garches, France

Industries

Voir plus
Ipsen
8 collaboration(s)
Dernière en 2023
Merz
6 collaboration(s)
Dernière en 2022
A+A
2 collaboration(s)
Dernière en 2021
FSK
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Concomitant Botulinum Neurotoxin Injections for NDO and Spasticity – A Retrospective Analysis of Practice and Safety From a Referral Center
Toxins 2024 7th International Conference   01 janvier 2024
MENOX: Efficacy of Intracavernosal (Xeomin®) 100U as add-on Therapy to Sildenafil 100 mg on Demand Compared to Sildenafil 100 mg on Demand for the Treatment of Erectile Dysfunction (ED) Not Sufficiently Responsive to Standard Therapy With Phosphodiesterase Type 5 Inhibitors
Essai Clinique (Assistance publique – Hôpitaux de Paris)   06 octobre 2023
Safety and Effectiveness of Repeated Botulinum Toxin A Intracavernosal Injections in Men with Erectile Dysfunction Unresponsive to Approved Pharmacological Treatments: Real-World Observational Data.
Toxins   05 juin 2023
Intravesical injections of botulinum neurotoxin A to treat overactive bladder and/or detrusor overactivity related to multiple sclerosis: 5-Year continuation rate and specific risk factors for discontinuation-A study from the neuro-urology committee of the French Association of Urology.
Multiple sclerosis (Houndmills, Basingstoke, England)   02 juin 2023
Intracavernosal OnabotulinumtoxinA Exerts a Synergistic Pro-Erectile Effect When Combined with Sildenafil in Spontaneously Hypertensive Rats.
The journal of sexual medicine   17 avril 2023
Intradetrusor botulinum toxin as the first-line treatment for neurogenic detrusor overactivity: Pro.
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie   07 janvier 2023
Long term effectiveness and safety of intracavernosal botulinum toxin a as an add-on therapy tophosphosdiesterase type 5 inhibitors or prostaglandin e1 injections for erectile dysfunction – a case series study
The journal of sexual medicine   01 novembre 2022
Intracavernosal onabotulinumtoxin a exerts a synergistic pro-erectile effect when combined with sildenafil in spontaneously hypertensive rats
The journal of sexual medicine   01 novembre 2022
Long term effectiveness and safety of intracavernosal botulinum toxin a as an add-on therapy tophosphosdiesterase type 5 inhibitors or prostaglandin e1 injections for erectile dysfunction – a case series study
The journal of sexual medicine   01 novembre 2022
Development and Assessment of Herpes Simplex Virus Type 1 (HSV-1) Amplicon Vectors with Sensory Neuron-Selective Promoters.
International journal of molecular sciences   30 juillet 2022